WHO Issues Recommendations for Tx Intensification in T2DM

Share this content:
WHO Issues Recommendations for Tx Intensification in T2DM
WHO Issues Recommendations for Tx Intensification in T2DM

WEDNESDAY, Sept. 5, 2018 (HealthDay News) -- Recommendations have been developed by the World Health Organization for treatment intensification in type 2 diabetes. The recommendations were published online Sept. 4 in the Annals of Internal Medicine.

Gojka Roglic, M.D., and Susan L. Norris, M.D., M.P.H., from the World Health Organization in Switzerland, developed recommendations to provide guidance on medicine selection for treatment intensification in type 2 diabetes, and use of insulin in type 1 and 2 diabetes.

The researchers developed five recommendations. One, a sulfonylurea should be given to patients with type 2 diabetes who do not achieve glycemic control with metformin alone or who have contraindications to metformin. Two, human insulin treatment should be introduced to patients with type 2 diabetes who do not achieve glycemic control with metformin and/or a sulfonylurea. Three, a dipeptidyl peptidase-4 inhibitor, a sodium-glucose contransporter-2 inhibitor, or a thiazolidinedione may be added if insulin is unsuitable. Four, in adults with type 1 diabetes, and in adults with type 2 diabetes for whom insulin is indicated, human insulin should be used to manage blood glucose. Five, long-acting insulin analogues should be considered to manage blood glucose in adults with type 1 or type 2 diabetes who have frequent, severe hypoglycemia with human insulin.

"The decision to name sulfonylureas as the single best second-line agent largely reflects the prioritization of cost and the recognition that WHO guidelines must apply to low-resource settings," write the authors of an accompanying editorial.

Abstract/Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

CDC: Many Americans May Have Prediabetes and Not Know It

CDC: Many Americans May Have Prediabetes and Not ...

AMA, CDC launch a campaign to raise awareness about prediabetes

Low-Carbohydrate Diets Linked to Increase in Calories Burned

Low-Carbohydrate Diets Linked to Increase in Calories Burned

Total energy expenditure is greater for those on a low- or moderate-carb diet during weight-loss maintenance

Many Patients Do Not Engage Health Care Provider During MS Relapse

Many Patients Do Not Engage Health Care Provider ...

Only half of patients reported always engaging health care providers

is free, fast, and customized just for you!




Already a member?

Sign In Now »